HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Heterozygous PAX6 mutations may lead to hyper-proinsulinaemia and glucose intolerance: A case-control study in families with congenital aniridia.

AbstractAIM:
PAX6 is a transcription factor involved in embryonic development of many organs, including the eyes and the pancreas. Mutations of PAX6 gene is the main cause of a rare disease, congenital aniridia (CA). This case-control study aims to investigate the effects of PAX6 mutations on glucose metabolism and insulin secretion in families with CA.
METHODS:
In all, 21 families with CA were screened by Sanger sequencing. Patients with PAX6 mutations and CA (cases) and age-matched healthy family members (controls) were enrolled. Oral glucose tolerance test (OGTT) was performed to detect diabetes or impaired glucose tolerance (IGT). Insulin and proinsulin secretion were evaluated.
RESULTS:
Among 21 CA families, heterozygous PAX6 mutations were detected in five families. Among cases (n = 10) from the five families, two were diagnosed with newly identified diabetes and another two were diagnosed with IGT. Among controls (n = 12), two had IGT. The levels of haemoglobin A1c were 36 ± 4 mmol/mol (5.57 ± 0.46%) and 32 ± 5 mmol/L (5.21 ± 0.54%) in the cases and the controls, respectively (p = 0.049). More importantly, levels of proinsulin in the cases were significantly higher than that of the controls, despite similar levels of total insulin. The areas under the curve of proinsulin in the cases (6425 ± 4390) were significantly higher than that of the controls (3709 ± 1769) (p = 0.032).
CONCLUSION:
PAX6 may participate in the production of proinsulin to insulin and heterozygous PAX6 mutations may be associated with glucose metabolism in CA patients.
AuthorsWei Tian, Xiao-Rong Zhu, Chun-Yan Qiao, Ying-Nan Ma, Fang-Yuan Yang, Zhen Zhou, Jian-Ping Feng, Ran Sun, Rong-Rong Xie, Jing Lu, Xi Cao, Jian-Bo Zhou, Jin-Kui Yang
JournalDiabetic medicine : a journal of the British Diabetic Association (Diabet Med) Vol. 38 Issue 2 Pg. e14456 (02 2021) ISSN: 1464-5491 [Electronic] England
PMID33169869 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2020 Diabetes UK.
Chemical References
  • C-Peptide
  • Glycated Hemoglobin A
  • Insulin
  • PAX6 Transcription Factor
  • PAX6 protein, human
  • hemoglobin A1c protein, human
  • Proinsulin
Topics
  • Adult
  • Aniridia (genetics)
  • C-Peptide (metabolism)
  • Case-Control Studies
  • Diabetes Mellitus (genetics, metabolism)
  • Diabetes Mellitus, Type 2 (genetics, metabolism)
  • Female
  • Glucose Intolerance (genetics, metabolism)
  • Glycated Hemoglobin (metabolism)
  • Heterozygote
  • Humans
  • Insulin (metabolism)
  • Male
  • Middle Aged
  • Mutation
  • PAX6 Transcription Factor (genetics)
  • Proinsulin (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: